98%
921
2 minutes
20
Background: Patient-powered research networks (PPRNs) for autoimmune disease are widely used in the adult population to recruit patients and drive patient-centered research, but few have included pediatric patients. We aimed to characterize viewpoints regarding research needs and participation in pediatric-onset multiple sclerosis (POMS) via a PPRN-disseminated survey.
Methods: This is an exploratory, cross-sectional study. The study period was February 1, 2022, to February 9, 2023. Three questionnaires were disseminated to (1) patients with POMS (PwPOMS), (2) caregivers of PwPOMS (C-PwPOMS), and (3) health care providers/researchers in POMS (HR-POMS).
Results: A total of 88 participants were included for analysis; 44% (n = 39) were PwPOMS, 42% (n = 37) were C-PwPOMS, and 14% (n = 12) were HR-POMS. Some PwPOMS (18%) and C-PwPOMS (9%) expressed research hesitancy, but more, 69% of PwPOMS and 68% of C-PwPOMS, were interested in research participation. Nevertheless, less than half of PwPOMS (38%) and C-PwPOMS (38%) reported previous research involvement. HR-POMS reported difficulties in funding (100%) and recruiting participants (58%). PwPOMS (67%), C-PwPOMS (62%), and HR-POMS (67%) were open to future involvement in PPRNs.
Conclusions: Participants with POMS in this study expressed strong interest in research involvement but also expressed participation hesitancy, which may contribute to recruiting challenges expressed by researchers. Although the exploratory design limits generalizability to the larger POMS population, this study shows PPRNs are well-suited to soliciting attitudes and opinions of key stakeholders in POMS. Future studies utilizing PPRNs for POMS should prioritize diverse, representative cohorts and focus on understanding and mitigating issues hindering research participation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pediatrneurol.2023.11.019 | DOI Listing |
Pediatr Surg Int
August 2025
Department of Pediatric Surgery, Hyogo Medical University, Mukogawa-Cho, Nishinomiya, Hyogo, 663-8501, Japan.
Purpose: To evaluate the impact of three-year Glucagon-like peptide 2 (GLP-2) analog therapy on parenteral nutrition (PN) dependency, intestinal rehabilitation, and quality of life in pediatric-onset short bowel syndrome (SBS).
Methods: Between August 2021 and December 2024, 18 pediatric-onset SBS patients underwent GLP-2-based intestinal rehabilitation. The remaining length of the small intestine ranged from 20 to 50 cm in adults and averaged 20 cm in children.
Children (Basel)
August 2025
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Children's, Cleveland, OH 44195, USA.
Background: Resilience is associated with improved outcomes in adult inflammatory bowel disease (IBD), yet little is known about its relationship to health-related quality of life and disease characteristics in pediatric-onset IBD.
Methods: This prospective, cross-sectional study enrolled pediatric-onset IBD patients (≥12 years) at Cleveland Clinic Children's. Participants completed the Connor-Davidson Resilience Scale (CD-RISC-10) and an age-appropriate health-related quality of life (HRQOL) survey.
J Affect Disord
August 2025
Department of Psychiatry, Washington University in Saint Louis, 660 Euclid Avenue, St. Louis, MO 63110, United States of America.
Background: Patients with pediatric bipolar disorder (PBD) have high risk of adolescent substance use disorders (SUD). Less is known about the risk of SUD into adulthood. This study analyzed the longitudinal associations between pediatric onset bipolar disorder and SUD from adolescence to adulthood.
View Article and Find Full Text PDFClin Cancer Res
August 2025
Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark.
Background: Cancer predisposition syndromes (CPSs) with pediatric onset are the leading known cause of childhood malignancies and are increasingly guiding clinical strategies in pediatric oncology. CPSs are placed under evolutionary negative selective pressure, but pediatric pancancer studies have so far failed to investigate genomic evolutionary metrics as a guide to predict penetrance and reveal novel CPSs.
Method: Germline whole-genome sequencing (WGS) in a 5-year prospective, registry-validated, nationwide cohort of individuals diagnosed with cancer before 18 years of age.
Cureus
July 2025
Department of Neurosurgery, Institute of Science Tokyo, Tokyo, JPN.
Moyamoya disease is characterized by bilateral stenosis of the terminal portions of the internal carotid arteries, whereas stenotic lesions in vertebrobasilar artery stenosis are reported less frequently. Moreover, de novo stenosis in these vessels during follow-up is exceptionally uncommon and rarely reported in the literature. Herein, we report two patients with pediatric-onset moyamoya disease who developed vertebrobasilar artery stenosis during follow-up after initial surgery.
View Article and Find Full Text PDF